TMEFF2 and endometrial carcinoma: Conversely, TMEFF2 was reported to exhibit oncogenic properties in endometrial carcinoma (EC), where its expression increased gradually through clinical stages, nodal metastasis and de-differentiation of endometrial tissue [58].